ArticleBMC ophthalmology2026
Comparison of ocular biometric parameters between nanophthalmos and primary angle closure disease: a cross-sectional comparative study.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare the ocular biometric parameters between eyes with nanophthalmos and primary angle closure disease (PACD).
methodsThis was a cross-sectional, comparative hospital-based study. A total of 144 subjects (144 eyes) including 58 nanophthalmos patients and 86 primary angle closure disease (26 primary angle closure and 60 primary angle closure glaucoma) patients were included in the study. The parameters studied were central corneal thickness (CCT), anterior chamber depth (ACD), anterior chamber angle (ACA), angle opening distance (AOD500 &AOD750), lens vault (LV), lens thickness (LT), axial length (AL), lens axial factor (LAF), relative lens position (RLP), and retinochoroido-scleral (RCS) thickness. All measurements were obtained prior to any laser or surgical intervention.
resultsThe mean ± SD age was comparable without any statistically significant difference across all the groups (57.3 ± 11 years in the nanopthalmos group,56.7 ± 9.3 years in the PAC group,56.1 ± 9.2 in the PACG group).The median IOP was highest in PAC eyes (17mmHg) followed by PACG eyes (16mmHg) and nanophthalmic eyes (14mmHg) (p = 0.003). A significant difference was found in ACA among the three groups (p = 0.003), PAC and PACG eyes exhibited wider angles (median 26
conclusionNanophthalmos represents a more anatomically crowded and complex entity compared to PACD, characterized by critical biometric alterations that predispose to severe angle closure. Comprehensive biometric evaluation is essential for early diagnosis, risk stratification, and individualized management planning in these eyes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.